Fortress Biotech, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Fortress Biotech, Inc. stock issued during period, value, stock options exercised for the quarter ending 2017-12-31 was $0.00.
- Fortress Biotech, Inc. stock issued during period, value, stock options exercised for the quarter ending 2017-09-30 was $0.00.
- Fortress Biotech, Inc. stock issued during period, value, stock options exercised for the quarter ending 2013-12-31 was $290.00K.
- Fortress Biotech, Inc. stock issued during period, value, stock options exercised for the quarter ending 2011-12-31 was $113.00K.
- Fortress Biotech, Inc. stock issued during period, value, stock options exercised for fiscal 2017 was $27.00K.
- Fortress Biotech, Inc. stock issued during period, value, stock options exercised for fiscal 2015 was $216.00K, a 63.76% decline from fiscal 2014.
- Fortress Biotech, Inc. stock issued during period, value, stock options exercised for fiscal 2014 was $596.00K, a 38.56% decline from fiscal 2013.
- Fortress Biotech, Inc. stock issued during period, value, stock options exercised for fiscal 2013 was $970.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $27.00K 10-K · filed 2019-03-18 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | |
| 2015-12-31 | $216.00K 10-K · filed 2018-03-16 | |
| 2014-12-31 | $596.00K 10-K · filed 2017-03-16 | |
| 2013-12-31 | $290.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $970.00K 10-K · filed 2016-03-15 |
| 2011-12-31 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $193.00K 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |